Awh Capital, L.P. Cyclerion Therapeutics, Inc. Transaction History

Awh Capital, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.46 - $8.39 $181,269 - $439,552	-52,390 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.37 - $7.14 $646,085 - $1.95 Million	-272,610 Reduced 83.88%	52,390 $310,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.84 $651,900 - $1.55 Million	-265,000 Reduced 44.92%	325,000 $861,000
Q4 2019 Feb 14, 2020	BUY	$1.8 - $13.43 $1.02 Million - $7.62 Million	567,093 Added 2475.63%	590,000 $1.61 Million
Q3 2019 Nov 14, 2019	BUY	$8.12 - $14.54 $103,935 - $186,112	12,800 Added 126.64%	22,907 $278,000
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $97,027 - $230,944	10,107 New	10,107 $116,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $62.2M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Awh Capital, L.P., based on Form 13F filings with the SEC.

Stay updated on Awh Capital, L.P. with notifications on news.